UPC APP 54214/2024

Oct 1, 2024·EP3056563: METHOD OF PRODUCING RETINAL PIGMENT EPITHELIAL CELL

Case details: Status
Case Closed
Action
Generic
Category
Document Access (RoP262)
Parties: Claimants
Mathys & Squire LLP
Reps: Mark Didmon (Potter Clarkson)
Respondents
ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE
Healios K.K
Riken
Osaka University
Mathys & Squire LLP
Reps: James Nicholls (JA Kemp); Pamela Tuxworth (JA Kemp)
Division: Munich CD
Judges: Ulrike Voß
Andras Kupecz
Paolo Gerli
Technology: Biotechnology
Language: English
First decided: Nov 4, 2024

Decisions

2024-11-04
Application Rop262 3
The Central Division (Munich) addressed Mathys & Squire LLP's request for access to pleadings under Rule 262.1(b) RoP in the Astellas v. Healios revocation action, ruling on confidentiality of certain pipeline information following the parties' settlement.
Legal issues:Public access to pleadings Rule 262.1(b) RoPConfidentiality Rule 262.2 RoPTrade secrets

Documents

Document title	Date	Public
Final Order anonymised	2024-11-05	Not public
Headnote-and-Keywords	2024-11-04	Not public
Outcome of the Order	2024-11-04	Not public
final order 262.3	2024-11-04	Public
final order 262.3	2024-11-04	Not public
Template-Order	2024-11-04	Not public
Letter to the Court	2024-10-18	Not public
preliminary order	2024-10-08	Not public
Receipt	2024-10-02	Not public
Formal-checks_Notification-of-positive-outcome	2024-10-02	Not public
Application under Rule 262.3	2024-10-01	Not public